Chicago Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Hold |
7,287
| – | – | 0.01% | 307 |
|
|
2025
Q1 | $282K | Sell |
7,287
-100
| -1% | -$3.87K | 0.01% | 295 |
|
|
2024
Q4 | $250K | Buy |
7,387
+100
| +1% | +$3.38K | 0.01% | 292 |
|
|
2024
Q3 | $298K | Hold |
7,287
| – | – | 0.01% | 266 |
|
|
2024
Q2 | $281K | Hold |
7,287
| – | – | 0.01% | 271 |
|
|
2024
Q1 | $312K | Sell |
7,287
-187
| -3% | -$8.02K | 0.01% | 252 |
|
|
2023
Q4 | $277K | Hold |
7,474
| – | – | 0.01% | 243 |
|
|
2023
Q3 | $271K | Buy |
7,474
+187
| +3% | +$6.78K | 0.01% | 197 |
|
|
2023
Q2 | $260K | Buy |
7,287
+187
| +3% | +$6.67K | 0.01% | 199 |
|
|
2023
Q1 | $253K | Hold |
7,100
| – | – | 0.01% | 203 |
|
|
2022
Q4 | $249K | Hold |
7,100
| – | – | 0.01% | 201 |
|
|
2022
Q3 | $209K | Sell |
7,100
-128
| -2% | -$3.77K | 0.01% | 218 |
|
|
2022
Q2 | $393K | Hold |
7,228
| – | – | 0.02% | 182 |
|
|
2022
Q1 | $394K | Hold |
7,228
| – | – | 0.02% | 194 |
|
|
2021
Q4 | $398K | Hold |
7,228
| – | – | 0.01% | 197 |
|
|
2021
Q3 | $345K | Hold |
7,228
| – | – | 0.01% | 204 |
|
|
2021
Q2 | $360K | Hold |
7,228
| – | – | 0.01% | 203 |
|
|
2021
Q1 | $322K | Sell |
7,228
-1,589
| -18% | -$70.8K | 0.01% | 205 |
|
|
2020
Q4 | $406K | Hold |
8,817
| – | – | 0.02% | 180 |
|
|
2020
Q3 | $415K | Hold |
8,817
| – | – | 0.02% | 169 |
|
|
2020
Q2 | $450K | Hold |
8,817
| – | – | 0.03% | 158 |
|
|
2020
Q1 | $418K | Hold |
8,817
| – | – | 0.03% | 147 |
|
|
2019
Q4 | $518K | Hold |
8,817
| – | – | 0.03% | 157 |
|
|
2019
Q3 | $470K | Hold |
8,817
| – | – | 0.03% | 161 |
|
|
2019
Q2 | $441K | Buy |
8,817
+3,642
| +70% | +$182K | 0.03% | 168 |
|
|
2019
Q1 | $270K | Buy |
+5,175
| New | +$270K | 0.02% | 188 |
|